MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/md.0000000000041615

Медицинская библиотека · Medicine · 2025

Melatonin for preventing postoperative delirium in elderly patients: A multicenter randomized placebo-controlled pilot study.

Khaled Maram, Chui Jason, Ewusie Joycelyne, Agzarian John, Bogach Jessica, Gomez Maria, Shayegan Bobby, Shargall Yaron, Alkhamesi Nawar, Paul James, Thabane Lehana, Shanthanna Harsha

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Postoperative delirium (POD) in older adults is associated with high risk of morbidity and mortality. With limited treatment options, prevention is essential. Melatonin has been suggested to prevent delirium through regulating the sleep-wake cycle and serotonin metabolism, which has been shown to be disrupted in patients with POD. However, the evidence regarding the use of melatonin for POD prevention is limited and inconclusive.

METHODS

Our multicenter, 2-arm, parallel-group, feasibility randomized controlled trial evaluated the effect of melatonin on POD incidence after noncardiac surgery in patients >65 years (n = 120). Patients were randomized to 3 mg oral melatonin or placebo once preoperatively and for 7 days postoperatively. Patients were assessed twice daily for delirium and followed at 3 months postoperatively. Feasibility outcomes were recruitment rate, medication adherence, and proportion completing 3-month follow-up. Clinical outcomes were delirium incidence, sleep quality, institutional discharge, and cognitive status at 3 months.

RESULTS

Between September 2021 and June 2023, 85 patients were randomized (~1 patient/wk); of these, 92.9% adhered to study medications and 87.1% completed the 3-month follow-up. POD occurred in 9 patients with no statistical difference between the groups (melatonin group, n = 7; placebo group, n = 2; adjusted odds ratio: 1.12; 95% confidence interval: 0.006-150.1). There were no differences in any other clinical outcomes. Pandemic-related challenges, including interruption of surgeries and restrictions on research procedures impacted feasibility and the study was terminated early due to futility.

CONCLUSIONS

Based on our observations, a sample size of >1000 patients is required for a definitive trial to evaluate the role of melatonin in reducing the incidence of POD. Design changes need to be considered to address feasibility challenges and ongoing post-pandemic modifications to patient care.

Для цитирования: Khaled Maram, Chui Jason, Ewusie Joycelyne, Agzarian John, Bogach Jessica, Gomez Maria, Shayegan Bobby, Shargall Yaron, Alkhamesi Nawar, Paul James, Thabane Lehana, Shanthanna Harsha. Melatonin for preventing postoperative delirium in elderly patients: A multicenter randomized placebo-controlled pilot study.. Medicine. 2025. DOI: 10.1097/md.0000000000041615.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.